Lanean...
Metabolism remodeling in pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is predicted to become the second leading cause of death of patients with malignant cancers by 2030. Current options of PDAC treatment are limited and the five-year survival rate is less than 8%, leading to an urgent need to explore innovatively therapeutic st...
Gorde:
| Argitaratua izan da: | Cell Stress |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Shared Science Publishers OG
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6883744/ https://ncbi.nlm.nih.gov/pubmed/31832601 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15698/cst2019.12.205 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|